“We are reprogramming another type of the immune system’s cells called T-cells, in order to teach them to fight the cancer inside the blood of the patient.”
Gamida Cell is a cell therapy company working to develop and commercialize cures for blood cancers and blood diseases.
American donors to Magen David Adom are building a new blood center for Israel to ensure there’s blood for civilians and soldiers when it’s needed most.
The company uses umbilical cord blood, which like bone marrow and peripheral blood, is a rich source of stem cells for transplantation.
Lead researcher Dr. Yaron Carmi believes that the treatment will be available within two years for human trials and compassionate use.